Literature DB >> 21330918

Innate immune response to influenza virus.

Shuhua Wu1, Jordan P Metcalf, Wenxin Wu.   

Abstract

PURPOSE OF REVIEW: The recent pandemic of a novel H1N1 influenza virus has stressed the importance of effective approaches to prevent viral infection. The innate immune system is our first line of defense against invading viruses. This review aims to give a brief summary of recent findings on the response of the innate immune system to influenza virus. RECENT
FINDINGS: Three families of pattern recognition receptors, toll-like receptors (TLRs), retinoic acid-inducible gene 1 protein like helicases (RLRs) and nucleotide-binding domain and leucine-rich-repeat-containing proteins (NLRs), are involved in recognition of influenza virus and they cooperatively operate to respond to the virus in cell culture or mouse models. Influenza virus mainly induces two types of innate immune cytokine responses: a proinflammatory response and an antiviral response. Recently, the NLRP3 inflammasome has proved to be an essential component in the host defense against influenza infection. The mitochondrion, traditionally recognized for its key role in respiration, metabolism and apoptosis, is becoming recognized as an important organelle for regulation of innate immune responses to influenza virus.
SUMMARY: The NLRP3 inflammasome is an essential component in the host defense against influenza infection. Further investigations are required to elucidate whether NLRP3 is associated with the adaptive response and to identify the components of influenza virus that activate this important mediator. The role of mitochondria as a potential central platform of innate response is becoming appreciated.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21330918     DOI: 10.1097/QCO.0b013e328344c0e3

Source DB:  PubMed          Journal:  Curr Opin Infect Dis        ISSN: 0951-7375            Impact factor:   4.915


  27 in total

1.  Clinical aspects and cytokine response in adults with seasonal influenza infection.

Authors:  Jia-Rong Bian; Wei Nie; Yuan-Sheng Zang; Zheng Fang; Qing-Yu Xiu; Xing-Xiang Xu
Journal:  Int J Clin Exp Med       Date:  2014-12-15

2.  Repeated Low-Dose Influenza Virus Infection Causes Severe Disease in Mice: a Model for Vaccine Evaluation.

Authors:  Yufeng Song; Xiang Wang; Hongbo Zhang; Xinying Tang; Min Li; Jufang Yao; Xia Jin; Hildegund C J Ertl; Dongming Zhou
Journal:  J Virol       Date:  2015-05-20       Impact factor: 5.103

3.  Elucidating influenza inhibition pathways via network reconstruction.

Authors:  Arnon Mazza; Irit Gat-Viks; Roded Sharan
Journal:  J Comput Biol       Date:  2014-01-22       Impact factor: 1.479

4.  The Induction of Pattern-Recognition Receptor Expression against Influenza A Virus through Duox2-Derived Reactive Oxygen Species in Nasal Mucosa.

Authors:  Hyun Jik Kim; Chang-Hoon Kim; Min-Ji Kim; Ji-Hwan Ryu; Sang Yeop Seong; Sujin Kim; Su Jin Lim; Michael J Holtzman; Joo-Heon Yoon
Journal:  Am J Respir Cell Mol Biol       Date:  2015-10       Impact factor: 6.914

5.  Distal airway stem cells yield alveoli in vitro and during lung regeneration following H1N1 influenza infection.

Authors:  Pooja A Kumar; Yuanyu Hu; Yusuke Yamamoto; Neo Boon Hoe; Tay Seok Wei; Dakai Mu; Yan Sun; Lim Siew Joo; Rania Dagher; Elisabeth M Zielonka; De Yun Wang; Bing Lim; Vincent T Chow; Christopher P Crum; Wa Xian; Frank McKeon
Journal:  Cell       Date:  2011-10-28       Impact factor: 41.582

6.  A direct and nonredundant role for thymic stromal lymphopoietin on antiviral CD8 T cell responses in the respiratory mucosa.

Authors:  Hillary L Shane; Kimberly D Klonowski
Journal:  J Immunol       Date:  2014-01-31       Impact factor: 5.422

7.  RIG-I and TLR3 are both required for maximum interferon induction by influenza virus in human lung alveolar epithelial cells.

Authors:  Wenxin Wu; Wei Zhang; Elizabeth S Duggan; J Leland Booth; Ming-Hui Zou; Jordan P Metcalf
Journal:  Virology       Date:  2015-04-11       Impact factor: 3.616

Review 8.  Some research advances of immune mechanism during infection in China.

Authors:  Wei Yang
Journal:  Sci China Life Sci       Date:  2012-01-07       Impact factor: 6.038

9.  Transforming Growth Factor-β and Interleukin-1β Signaling Pathways Converge on the Chemokine CCL20 Promoter.

Authors:  Oliver J Brand; Sangeeta Somanath; Catherine Moermans; Haruhiko Yanagisawa; Mitsuo Hashimoto; Stephanie Cambier; Jennifer Markovics; Andrew J Bondesson; Arthur Hill; David Jablons; Paul Wolters; Jianlong Lou; James D Marks; Jody L Baron; Stephen L Nishimura
Journal:  J Biol Chem       Date:  2015-04-27       Impact factor: 5.157

10.  Recombinant Hemagglutinin and Virus-Like Particle Vaccines for H7N9 Influenza Virus.

Authors:  Xiaohui Li; Peter Pushko; Irina Tretyakova
Journal:  J Vaccines Vaccin       Date:  2015-06-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.